GlassScriptPhysician profile
Robert G Thompson
NPI 1154418580
$1,954.67
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $695 · 2020: $273 · 2021: $469 · 2022: $518.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $461.90 | 2019-2022 | |
| Novo Nordisk INC | $220.28 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $211.72 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $147.20 | 2019-2022 | |
| Amarin Pharma, INC. | $104.54 | 2019-2021 | |
| Esperion Therapeutics, INC. | $101.51 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $101.04 | 2022 | |
| Lilly USA, LLC | $73.38 | 2019-2020 | |
| United Therapeutics Corporation | $70.60 | 2019-2021 | |
| Indivior INC. | $70.08 | 2019-2022 | |
| Corcept Therapeutics | $65.06 | 2019-2021 | |
| Edwards Lifesciences Corporation | $53.91 | 2019 | |
| Pfizer INC. | $51.36 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $50.39 | 2021-2022 | |
| Horizon Therapeutics Plc | $50.13 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $38.50 | 2019 | |
| Sanofi-Aventis U.S. LLC | $37.70 | 2019 | |
| Boston Scientific Corporation | $27.20 | 2022 | |
| Ironshore Pharmaceuticals INC. | $18.17 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.